Covid19 Antigen testing kit is used for test patrons on Covid19 symptoms.
The FactView Vitamin D Rapid Test Device is a diagnostic assay used for the qualitative detection of Vitamin D levels in blood samples. Here's more information about this type of diagnostic test: Purpose: The test is used for the rapid detection of Vitamin D deficiency or insufficiency. Vitamin D is essential for bone health, immune function, and various other physiological processes in the body. Principle: The FactView Vitamin D Rapid Test Device is typically an immunochromatographic assay that detects the presence of Vitamin D in a patient's blood sample. The test device contains specific antibodies or receptors that bind to Vitamin D molecules, leading to the formation of visible test lines. Components: The test kit usually includes test cassettes, sample droppers, buffer solutions, and desiccants. The test cassettes contain pre-coated membranes with specific reagents for capturing Vitamin D molecules. Procedure: The test procedure involves collecting a small amount of blood from the patient (usually obtained via finger prick) and applying it to the sample well of the test cassette. Buffer solution is then added, allowing the blood sample to migrate along the test strip. Results are typically visible within a few minutes. Interpretation: The appearance of colored lines on the test strip indicates the presence or absence of Vitamin D in the blood sample. A visible line in the control region indicates that the test is valid. Additional lines in the test region(s) indicate positive results for Vitamin D. Sensitivity and Specificity: The FactView Vitamin D Rapid Test Device demonstrates sensitivity and specificity for detecting Vitamin D levels within a certain range. However, like all diagnostic tests, false-positive and false-negative results are possible and should be interpreted in conjunction with clinical findings. Utility: The rapid detection of Vitamin D levels provides valuable information for assessing Vitamin D status, identifying deficiency or insufficiency, and guiding patient management decisions. Vitamin D deficiency is associated with various health problems, including bone disorders, immune dysfunction, and increased risk of certain diseases. Limitations: While rapid diagnostic tests are useful for Vitamin D screening, they have limitations compared to more accurate laboratory methods such as liquid chromatography-mass spectrometry (LC-MS). Factors such as test sensitivity, specificity, and the influence of interfering substances can affect test performance. Overall, the FactView Vitamin D Rapid Test Device is a convenient tool for assessing Vitamin D levels, allowing for timely intervention and management of Vitamin D-related health conditions. However, results should be interpreted carefully in conjunction with clinical evaluation and other laboratory tests.
"FactView Malaria Rapid PF/PV" likely refers to a diagnostic test for the rapid detection of Plasmodium falciparum (PF) and Plasmodium vivax (PV), two species of malaria parasites. Here's more information about this type of diagnostic test: Purpose: The FactView Malaria Rapid PF/PV test is used for the rapid detection of malaria infection caused by the Plasmodium falciparum and Plasmodium vivax parasites. Malaria is a serious infectious disease transmitted by the bite of infected Anopheles mosquitoes. Principle: The test is based on immunochromatographic principles, where specific antibodies are used to detect the presence of malaria antigens in a patient's blood sample. The presence of the PfHRP2 antigen indicates P. falciparum infection, while the presence of the pLDH antigen indicates P. vivax infection. Components: The FactView Malaria Rapid PF/PV test typically includes test cassettes, sample droppers, buffer solutions, and desiccants. The test cassettes contain pre-coated membranes with specific antibodies for detecting malaria antigens. Procedure: The test procedure involves collecting a small amount of blood from the patient (usually obtained via finger prick) and applying it to the sample well of the test cassette. Buffer solution is then added, allowing the blood sample to migrate along the test strip. Results are typically visible within 15-20 minutes. Interpretation: The appearance of colored lines on the test strip indicates the presence or absence of malaria antigens. A visible line in the control region indicates that the test is valid. Additional lines in the test regions indicate positive results for P. falciparum and/or P. vivax antigens. Sensitivity and Specificity: The FactView Malaria Rapid PF/PV test demonstrates high sensitivity and specificity for detecting malaria infections caused by P. falciparum and P. vivax parasites. However, like all diagnostic tests, false-positive and false-negative results are possible and should be interpreted in conjunction with clinical findings. Utility: Rapid diagnostic tests like the FactView Malaria Rapid PF/PV provide a quick and convenient method for diagnosing malaria infections in resource-limited settings, where access to laboratory facilities and microscopy may be limited. Limitations: While rapid diagnostic tests are valuable tools for malaria diagnosis, they have limitations compared to more sensitive methods such as microscopy or molecular testing. Factors such as test storage conditions, operator technique, and the stage of infection can influence test performance.
Flowflex antigen kits
HbsAg RAPID TEST KIT
Globally acclaimed Covid Test kits , the best of brands with CE and other requisite certificates are available at a fantastic price ( PanBio/ Flowflex/ Sd Bio sensor) . Delivery all over the globe in 2/ 5 days vide air cargo. We hold the biggest stocks in India. Pl note , prices are quantum based and fluctuate as per demand and supply.
Rapid testing kits for HIV, HCV, COVID, Malaria, Dengue, HBsAg,
HCG Test is an immunochromatographic assay designed for qualitative determinatrion of human chronic gonadotropin (hCG) in urine for the detection of pregnancy. Human chorionic gonadotropin is a glycopeptide hormone produced by the placenta during pregnancy. The apprearance and rapid rise in the concentration of hCG in the woman''s urine makes it good pregnancy marker. Usually, concentration of hCG in urine is at least 25mlU/ml within seven to ten days after conception. Justifying our reputation in this market, we are readily immersed in the arena of offering to our patrons a broad consignment of HCG Tests Kits. Sensitivity 25 miu Features: Precise design Durable Good quality
A one-step rapid immunochromatographic test for the quantitative detection of specific antibodies to COVID-19 present in human serum, plasma, or whole blood.
All types of Rapid test kits
Anti-SARS-CoV-2 Rapid Test, COVID-19 1. Easier: No special equipment needed, Intuitive visual interpretation. 2. Rapid: Quick sampling by fingertip blood, Results in 10-15min. 3. Accurate: Results with IgG and IgM respectively. 4. Application: as screening tool for potential suspect patients in large numbers. Testing kit is FDA Emergency Use Authorization (EUA) Approved Testing kit is CE MARKED-IVD * Instruction for Use * Interpretation Guide * SARS-CoV-2 immunoassays * Accuracy of the Anti-SARS-CoV-2 Rapid Test Kit * Anti-SARS Rapid Test Brochure * COVID-19 Catalog * EUA Approval Letter * Fact Sheet for Healthcare Providers * FDA Letter * Fact Sheet for Recipients * FAQ * CE IVD Notification Certificate Antibody Performance Measure Estimate of Performance 95% Confidence Interval IgM Sensitivity (PPA) 95.7% (289/302) (92.8%; 97.5%) IgM Specificity (NPA) 99.7% (311/312) (98.2%; 99.9%) IgG Sensitivity (PPA) 99.0% (299/302) (97.1%; 99.7%) IgG Specificity (NPA) 99.4% (310/312) (97.7%; 99.8%) Combined Sensitivity (PPA) 99.0% (299/302) (97.1%; 99.7%) Combined Specificity (NPA) 99% (309/312) (97.2%; 99.7%) Combined PPV at prevalence = 5% 84.4% (64.6%; 94.6%) Combined NPV at prevalence = 5% 99.9% (99.8%; 100%) Testing kit is FDA Emergency Use Authorization (EUA) Approved Testing kit is CE MARKED-IVD * Instruction for Use * Interpretation Guide * SARS-CoV-2 immunoassays * Accuracy of the Anti-SARS-CoV-2 Rapid Test Kit * Anti-SARS Rapid Test Brochure * COVID-19 Catalog * EUA Approval Letter * Fact Sheet for Healthcare Providers * FDA Letter * Fact Sheet for Recipients * FAQ * CE IVD Notification Certificate
Product Details: Number of Reactions(Preps)/Kit :30T Brand : SD Biosensor ICMR Approved : Yes Result Time (Rapid Kits) : 10 min CAT No : RK019-30 STANDARD Q HIV 1/2 Ab 3-Line performs qualitative analysis by detecting antibodies specific to HIV-1 (including Group O) and HIV-2 in serum, plasma and whole blood using immunochromatography. With a simple test method, HIV infection status can be discriminated, and with its high sensitivity and specificity, the screening test result can be obtained within 10 minutes. Easy to use, Easy to read and interpret Discrimination between HIV-1 and HIV-2 antibodies Room temperature storage Performance Sensitivity : 100% (74/74)/ Specificity : 100% (232/232)
A rapid in vitro qualitative immunoassay for detection of antibodies to the Human Immunodeficiency Virus Type 1 (HIV-1) and Type 2 (HIV-2) Clear, dependable results in 15 minutes Requires minimal training and no equipment So easy it can be used at the lowest levels of health care service Can use whole blood or serum/plasma Collection can be by fingerstick or venipuncture No refrigeration required Storage conditions 2-30�°C
COVID-19 Ag Rapid Test Device is an in vitro diagnostic rapidtest for the qualitative detection of antigen (Ag) in humannasopharyngeal swab specimens from individuals who meet COVID-19clinical and / or epidemiological criteria. COVID-19 Ag RapidTest Device is for professional use only and is intended to be used asan aid in the diagnosis of
COVID-19 serology test.Cellex qSARS-CoV-2 IgG/IgM Rapid Test.qSARS-CoV-2 IgG/IgM Rapid Test Cassette.FDA Grants Emergency Authorization for First Rapid Antibody Test for COVID-19
CAT No : RCHM-02071. The CareStar COVID-19 Antigen test is a lateral flow immunochromatographic assay intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal or anterior nasal swab specimens directly collected from individuals who are either suspected of COVID-19 by their healthcare provider within first five days of symptom onset, or from individuals without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over two or three days with at least 24 hours and no more than 48 hours between tests.
Hand held glue spreader. 1 unit per box.
Test Method (SARS-CoV-2) RT-PCR Result Time (Rapid Kits) 30mins The Viral/Pathogen Nucleic Acid Isolation Kit is designed to recover RNA and DNA from virus and gram-negative bacteria in samples such as blood, swabs, urine, and viral transport media (VTM). The kit utilizes magnetic-bead technology, ensuring reproducible recovery of high-quality nucleic acid compatible with a broad range of applications, including real-time PCR, digital PCR, and next-generation sequencing.
COVID-19 Chip-based Real Time PCR Test is a semi quantitative detection of RNA in human oropharyngeal and nasopharyngeal swab specimen and aids in detection and confirmation of infection and diagnosis of COVID-19. The test detects the E and Orf1a genes of the virus.
